Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alvotech (ALVO)

Alvotech (ALVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,528,514
  • Shares Outstanding, K 301,482
  • Annual Sales, $ 489,680 K
  • Annual Income, $ -231,860 K
  • EBIT $ 11 M
  • EBITDA $ 101 M
  • 60-Month Beta 0.13
  • Price/Sales 2.84
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 0.13
  • Number of Estimates 1
  • High Estimate 0.13
  • Low Estimate 0.13
  • Prior Year -0.24
  • Growth Rate Est. (year over year) +154.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.32 +26.62%
on 12/03/25
5.85 -6.50%
on 11/10/25
+0.59 (+12.09%)
since 11/05/25
3-Month
4.32 +26.62%
on 12/03/25
9.25 -40.86%
on 09/23/25
-2.86 (-34.33%)
since 09/05/25
52-Week
4.32 +26.62%
on 12/03/25
13.70 -60.07%
on 01/13/25
-5.99 (-52.27%)
since 12/05/24

Most Recent Stories

More News
Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action Investigation – ALVO

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Alvotech (NASDAQ: ALVO) resulting from allegations...

ALVO : 5.47 (+7.89%)
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman

ALVO Investors with Losses Encouraged to Contact the Firm

ALVO : 5.47 (+7.89%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alvotech - ALVO

NEW YORK , Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Alvotech ("Alvotech" or the "Company") (NASDAQ: ALVO). Such investors are advised to contact...

ALVO : 5.47 (+7.89%)
ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP

The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Alvotech (“Alvotech” or the “Company”) (NASDAQ:ALVO) investors concerning the Company’s and/or...

ALVO : 5.47 (+7.89%)
ALVO ALERT: Levi & Korsinsky Investigates Alvotech for Possible Securities Fraud Violations

New York, New York--(Newsfile Corp. - November 13, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Alvotech ("Alvotech") (NASDAQ: ALVO) concerning possible violations...

ALVO : 5.47 (+7.89%)
Alvotech (ALVO) Faces Investor Scrutiny Amid Manufacturing Deficiencies Severely Impacting Assurances of 2025 Revenues and Adjusted EBITDA, Stock Tumbles 33% -- Hagens Berman

ALVO Investors with Losses Encouraged to Contact Hagens Berman

ALVO : 5.47 (+7.89%)
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Alvotech (NASDAQ: ALVO) and Encourages Investors with Substantial Losses to Contact the Firm

NEWTOWN, Pa. , Nov. 10, 2025 /PRNewswire/ -- Edelson Lechtzin LLP  is investigating potential violations of the federal securities laws involving Alvotech ("Alvotech" or "the Company") (NASDAQ:...

ALVO : 5.47 (+7.89%)
Alvotech’s AVT23 Biosimilar Gains EMA Acceptance

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Alvotech...

ALVO : 5.47 (+7.89%)
Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab)

Kashiv Biosciences has submitted its Biologics License Applications (BLA) for ADL-018 as a biosimilar to reference product XOLAIR® (omalizumab) to the U.S. Food and Drug Administration (FDA) ...

ALVO : 5.47 (+7.89%)
AMRX : 12.18 (+2.01%)
Kodiak Q2 Loss Wider Than Expected, Pipeline Development in Focus

Kodiak Sciences KOD incurred a loss of $1.03 per share in the second quarter of 2025, wider than the Zacks Consensus Estimate of a loss of $1.01. The company had incurred a loss of 86 cents per share...

KOD : 24.34 (-1.70%)
CRMD : 10.56 (-0.75%)
ALVO : 5.47 (+7.89%)
ZYME : 26.69 (+0.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Alvotech Holdings S.A. is a biotech company. It focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech Holdings S.A., formerly known as Oaktree Acquisition Corp. II, is based in REYKJAVIK, Iceland.

See More

Key Turning Points

3rd Resistance Point 6.00
2nd Resistance Point 5.75
1st Resistance Point 5.61
Last Price 5.47
1st Support Level 5.21
2nd Support Level 4.96
3rd Support Level 4.82

See More

52-Week High 13.70
Fibonacci 61.8% 10.12
Fibonacci 50% 9.01
Fibonacci 38.2% 7.90
Last Price 5.47
52-Week Low 4.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar